-
Je něco špatně v tomto záznamu ?
Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems
AA. Kudryavtseva, E. Cséfalvay, EY. Gnuchikh, DD. Yanovskaya, MA. Skutel, AB. Isaev, SV. Bazhenov, AA. Utkina, IV. Manukhov
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- Publikační typ
- časopisecké články MeSH
ArdB, ArdA, and Ocr proteins inhibit the endonuclease activity of the type I restriction-modification enzymes (RMI). In this study, we evaluated the ability of ArdB, ArdA, and Ocr to inhibit different subtypes of Escherichia coli RMI systems (IA, IB, and IC) as well as two Bacillus licheniformis RMI systems. Furthermore we explored, the antirestriction activity of ArdA, ArdB, and Ocr against a type III restriction-modification system (RMIII) EcoPI and BREX. We found that DNA-mimic proteins, ArdA and Ocr exhibit different inhibition activity, depending on which RM system tested. This effect might be linked to the DNA mimicry nature of these proteins. In theory, DNA-mimic might competitively inhibit any DNA-binding proteins; however, the efficiency of inhibition depend on the ability to imitate the recognition site in DNA or its preferred conformation. In contrast, ArdB protein with an undescribed mechanism of action, demonstrated greater versatility against various RMI systems and provided similar antirestriction efficiency regardless of the recognition site. However, ArdB protein could not affect restriction systems that are radically different from the RMI such as BREX or RMIII. Thus, we assume that the structure of DNA-mimic proteins allows for selective inhibition of any DNA-binding proteins depending on the recognition site. In contrast, ArdB-like proteins inhibit RMI systems independently of the DNA recognition site.
Center of Cellular and Molecular Biology Skolkovo Institute of Science and Technology Moscow Russia
Faculty of Physics HSE University Moscow Russia
Kurchatov Genomic Center National Research Center Kurchatov Institute Moscow Russia
Laboratory for Microbiology BIOTECH University Moscow Russia
Laboratory for Molecular Genetics Moscow Institute of Physics and Technology Dolgoprudny Russia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23009970
- 003
- CZ-PrNML
- 005
- 20230721095400.0
- 007
- ta
- 008
- 230707s2023 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fmicb.2023.1133144 $2 doi
- 035 __
- $a (PubMed)37138625
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kudryavtseva, Anna A $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
- 245 10
- $a Broadness and specificity: ArdB, ArdA, and Ocr against various restriction-modification systems / $c AA. Kudryavtseva, E. Cséfalvay, EY. Gnuchikh, DD. Yanovskaya, MA. Skutel, AB. Isaev, SV. Bazhenov, AA. Utkina, IV. Manukhov
- 520 9_
- $a ArdB, ArdA, and Ocr proteins inhibit the endonuclease activity of the type I restriction-modification enzymes (RMI). In this study, we evaluated the ability of ArdB, ArdA, and Ocr to inhibit different subtypes of Escherichia coli RMI systems (IA, IB, and IC) as well as two Bacillus licheniformis RMI systems. Furthermore we explored, the antirestriction activity of ArdA, ArdB, and Ocr against a type III restriction-modification system (RMIII) EcoPI and BREX. We found that DNA-mimic proteins, ArdA and Ocr exhibit different inhibition activity, depending on which RM system tested. This effect might be linked to the DNA mimicry nature of these proteins. In theory, DNA-mimic might competitively inhibit any DNA-binding proteins; however, the efficiency of inhibition depend on the ability to imitate the recognition site in DNA or its preferred conformation. In contrast, ArdB protein with an undescribed mechanism of action, demonstrated greater versatility against various RMI systems and provided similar antirestriction efficiency regardless of the recognition site. However, ArdB protein could not affect restriction systems that are radically different from the RMI such as BREX or RMIII. Thus, we assume that the structure of DNA-mimic proteins allows for selective inhibition of any DNA-binding proteins depending on the recognition site. In contrast, ArdB-like proteins inhibit RMI systems independently of the DNA recognition site.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cséfalvay, Eva $u Laboratory of Structural Biology and Bioinformatics, Institute of Microbiology, Academy of Sciences of the Czech Republic, Nové Hrady, Czechia
- 700 1_
- $a Gnuchikh, Evgeniy Yu $u Kurchatov Genomic Center, National Research Center Kurchatov Institute, Moscow, Russia
- 700 1_
- $a Yanovskaya, Darya D $u Center of Cellular and Molecular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia
- 700 1_
- $a Skutel, Mikhail A $u Center of Cellular and Molecular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia
- 700 1_
- $a Isaev, Artem B $u Center of Cellular and Molecular Biology, Skolkovo Institute of Science and Technology, Moscow, Russia
- 700 1_
- $a Bazhenov, Sergey V $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia $u Laboratory for Microbiology, BIOTECH University, Moscow, Russia $u Faculty of Physics, HSE University, Moscow, Russia
- 700 1_
- $a Utkina, Anna A $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia
- 700 1_
- $a Manukhov, Ilya V $u Laboratory for Molecular Genetics, Moscow Institute of Physics and Technology, Dolgoprudny, Russia $u Laboratory for Microbiology, BIOTECH University, Moscow, Russia $u Faculty of Physics, HSE University, Moscow, Russia
- 773 0_
- $w MED00181714 $t Frontiers in microbiology $x 1664-302X $g Roč. 14, č. - (2023), s. 1133144
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37138625 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230707 $b ABA008
- 991 __
- $a 20230721095353 $b ABA008
- 999 __
- $a ok $b bmc $g 1958583 $s 1196234
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 14 $c - $d 1133144 $e 20230417 $i 1664-302X $m Frontiers in microbiology $n Front Microbiol $x MED00181714
- LZP __
- $a Pubmed-20230707